Last Price
74.54
Today's Change
+0.04 (0.05%)
Day's Change
72.90 - 75.28
Trading Volume
1,391,865
Market Cap
12 Billion
Shares Outstanding
161 Million
Avg Volume
3,603,116
Avg Price (50 Days)
58.90
Avg Price (200 Days)
34.87
PE Ratio
-14.25
EPS
-5.23
Earnings Announcement
01-Aug-2024
Previous Close
74.50
Open
75.28
Day's Range
72.9 - 75.28
Year Range
20.48 - 78.87
Trading Volume
1,391,865
1 Day Change
0.05%
5 Day Change
-1.48%
1 Month Change
8.06%
3 Month Change
200.56%
6 Month Change
169.00%
Ytd Change
148.96%
1 Year Change
266.11%
3 Year Change
211.88%
5 Year Change
223.24%
10 Year Change
335.91%
Max Change
-54.82%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.